22,335
edits
Changes
Jump to navigation
Jump to search
m
wikify HIV
|DOI=10.1111/j.1464-410X.2005.05810.x
|accessdate=
}}</ref> which are being used by the [[World Health Organization]] (under the guide of [[UNAIDS]]) to endorse circumcision as an [[HIV ]] prevention method.<ref>{{REFweb
|last=World Health Organization
|first=
== Interests ==
According to Stephen's bio, his interest is in biological and behavioural risk factors for STI/[[HIV ]] transmission.<ref name='moses-bio'>{{REFweb
|last=Moses
|first=Stephen
|url=https://www.doctorsopposingcircumcision.org/for-professionals/alleged-medical-benefits/hivaids/
|accessdate=2020-03-23
}}</ref>Of the three {{#tip-text:RCT|Randomized controlled trial}}s being used by the [[WHO]] to endorse circumcision as [[HIV ]] prevention, Stephen Moses and [[Robert C. Bailey]] headed the {{#tip-text:RCT|Randomized controlled trial}} that was carried out in Kenya.<ref>Bailey RC, Moses S, Parker CB, et al. Male circumcision for [[HIV ]] prevention in young men in Kisumu, Kenya: a randomised controlled trial. ''Lancet'' 2007;369:643-56. [http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(07)60312-2/abstract Abstract]</ref> Moses obviously brought his pre-existing bias in favor of male circumcision into the trial, so he did not start from a neutral position.
Moses' research on circumcision protection from [[HIV ]] infection is now completely discredited. Boyle & Hill (2011) reviewed the three randomized controlled trials (RCTs) and found disabling methodological and statistical errors in all three. Although a 60 percent ''relative'' reduction in [[HIV ]] was claimed, the ''absolute'' reduction was a statistically insignificant 1.3 percent.<ref name="boyle-hill2011">{{BoyleGJ HillG 2011}}</ref> Garenne & Matthews (2019) report that circumcised men have as much [[HIV ]] infection as intact men.<ref>{{REFjournal
|last=Garenne
|init=M
== Active projects ==
* A randomized, controlled trial of male circumcision to reduce [[HIV ]] incidence in Kisumu, Kenya.<ref name='moses-bio'/><br><small>[[National Institutes of Health]].</small>* Scaling up [[HIV ]] prevention in Karnataka and southern Maharashtra, Phase II.<ref name='moses-bio'/><br><small>[[Bill & Melinda Gates Foundation]].</small>
* Monitoring and evaluation of the Avahan project in India.<ref name='moses-bio'/><br><small>[[Bill & Melinda Gates Foundation]].</small>
* Technical assistance to improve maternal, neonatal & child health through National Rural Health Mission, India.<ref name='moses-bio'/><br><small>[[Bill & Melinda Gates Foundation]].</small>
* Mapping key populations for [[HIV ]] prevention in Sri Lanka.<ref name='moses-bio'/><br><small>World Bank.</small>
== Recent publications ==
|accessdate=
}}</ref><br><small>Smith JS, Hudgens MG, '''[[Robert C. Bailey|Bailey RC]]''', Agot K, Ndinya-Achola JO, Moses S, et al. Int J Cancer 2010; 126: 572-7.</small>
* Top Achievements in Health Research: Male circumcision: a new approach to reducing [[HIV ]] transmission.<ref>{{REFjournal
|last=Moses
|init=S
|accessdate=
}}</ref><br><small>Moses S. CIHR/CMAJ 2009; 181: E134-5.</small>
* Does sex in the early period after circumcision increase [[HIV]]-seroconversion risk? Pooled analysis of adult male circumcision clinical trials.<ref>{{REFjournal
|last=Mehta
|init=SD
}}
</ref><br><small>Mehta SD, '''[[Ronald Gray|Gray RH]]''', '''[[Bertran Auvert|Auvert B]]''', Moses S , Kigozi G, Taljaard D, Puren A, Agot K, Serwadda D, Parker CB, '''[[Maria Wawer|Wawer MJ]]''', '''[[Robert C. Bailey|Bailey RC]]'''. AIDS 2009; 23: 1557-64.</small>
* Male circumcision for [[HIV ]] prevention in young men in Kisumu, Kenya: a randomised controlled trial.<ref>{{REFjournal
|last=Bailey
|init=RC
}}
</ref><br><small>'''[[Robert C. Bailey|Bailey RC]]''', Moses S , Parker CB, Agot K, Maclean I, Krieger JN, et al. Lancet 2007; 369: 643-56.</small>
* Modelling the public health impact of male circumcision for [[HIV ]] prevention in high prevalence areas in Africa.<ref>{{REFjournal
|last=Nagelkerke
|init=NJ